Swiss researchers developed a skin implant device with genetic components, called a biomedical tattoo, which monitors blood calcium levels to help detect breast, colon, lung and prostate cancers early. The implant has shown promise in mice models and pig skin and has proven to be cost-effective, but more studies are needed before the implant can be tested on humans, researchers report in Science Translational Medicine.